Cargando...
Antitumor effects of anlotinib in thyroid cancer
There is no effective treatment for patients with poorly differentiated papillary thyroid cancer or anaplastic thyroid cancer (ATC). Anlotinib, a multi-kinase inhibitor, has already shown antitumor effects in various types of carcinoma in a phase I clinical trial. In this study, we aimed to better u...
Guardado en:
| Publicado en: | Endocr Relat Cancer |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Bioscientifica Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6215907/ https://ncbi.nlm.nih.gov/pubmed/30139768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-17-0558 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|